Loading company…
Cambridge, US biotechnology company developing cellular immunotherapies for cancer treatment.
Founded in 2015 and based in Cambridge, US, Torque Therapeutics develops cellular immunotherapies that aim to strengthen the immune system's response to tumors, including engineered T cells for specific tumor types. Its therapies are being tested in clinical trials for solid tumors and hematological malignancies. In November 2017 the company raised USD 25 million in Series A funding led by Flagship Pioneering, and Michael Wachholz serves as CEO and founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in